Kepler Capital Keeps Their Buy Rating on Novartis AG (NOVN)
Novartis AG: Stable Outlook With Mixed Product Performance and Favorable Forex Impact Justifies Hold Rating
AlphaValue/Baader Europe Lifts Novartis Price Target on Upbeat Earnings Outlook
BNP Paribas Initiates Novartis at Outperform Rating, $116 Price Target
Novartis AG (NOVN) Receives a Hold From J.P. Morgan
UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)
Bernstein Reaffirms Their Buy Rating on Novartis AG (NOVN)
Barclays Reaffirms Their Sell Rating on Novartis AG (NOVN)
Kepler Capital Keeps Their Buy Rating on Novartis AG (NOVN)
Berenberg Bank Keeps Their Hold Rating on Novartis AG (NOVN)
Novartis AG (NOVN) Gets a Buy From Kepler Capital
Novartis AG (NOVN) Gets a Buy From Deutsche Bank
DA Davidson Downgrades Novartis to Neutral From Buy, Price Target Is $120
J.P. Morgan Sticks to Their Hold Rating for Novartis AG (NOVN)
Deutsche Bank Keeps Their Buy Rating on Novartis AG (NOVN)
Novartis Analyst Ratings
Novartis AG (NOVN) Gets a Buy From Deutsche Bank
Novartis Target Cut to CHF104 From CHF111 by UBS
Novartis Cut to Neutral From Buy by UBS
UBS Downgrades Novartis AG (NOVN) to a Hold